Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial

التفاصيل البيبلوغرافية
العنوان:	Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial
المؤلفون:	Huang, Hai-Tao, Li, Xiao-Long, Wang, Xue, Wan, Peng, Zhu, Tao, Tang, Rong ^, Zheng, Hui ^, Wang, Bu-Sen ^, Gou, Jin-Bo ^, Guo, Xi-Ling, Chen, Xiao-Qin, Chen, Yin, Wu, Shi-Po, Zhong, Jin, Pan, Hong-Xing, Zhu, Jia-Hong, Xu, Xiao-Yu, Shi, Feng-Juan, Li, Zhuo-Pei, Liu, Jing-Xian, Zhang, Xiao-Yin, Cui, Lun-Biao, Song, Zhi-Zhou, Hou, Li-Hua ^, Zhu, Feng-Cai ^, Li, Jing-Xin ^*
المصدر:	In The Lancet Respiratory Medicine July 2023 11(7):613-623
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	22132600
DOI:	10.1016/S2213-2600(23)00049-8